Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this week’s Pathways Picks: The Council of the European Union recommends changes and urges quick action on MDR/IVDR reforms; FDA and UK regulators embed liaisons to improve collaboration; CMS proposes expanded TAVR coverage; and more from Europe, the US, and Asia.
Watchful waiting has hitherto been the best course for smaller abdominal aortic aneurysms, although they are likely to grow, and could unexpectedly rupture. There is hope on the horizon; Nectero recently published two-year FIH data, and Angiolutions emerges with what its founders call a first-in-class mechanobiological device strategy.
Health ministers push for changes and action on MDR/IVDR reforms. Excerpted from Pathways’ Picks June 17: EU Health Ministers Weigh Reforms, UK-US Liaisons, and TAVR Milestone.